R Sjöström. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAge FactorsAgedBipolar Disorder/bloodBipolar Disorder/cerebrospinal fluidBipolar Disorder/drug therapyBody WeightClinical Trials as TopicFemaleHalf-LifeHomovanillic Acid/cerebrospinal fluidHumansHydroxyindoleacetic Acid/cerebrospinal fluidKineticsMaleMiddle AgedPhenylacetates/cerebrospinal fluidProbenecid/bloodProbenecid/cerebrospinal fluidProbenecid/therapeutic useProtein BindingRegression AnalysisStatistics as TopicTime Factors
Substances: See more » PhenylacetatesHydroxyindoleacetic AcidProbenecidHomovanillic Acid
Year: 1973 PMID: 4588853 DOI: 10.1007/bf00562430
Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN: 0031-6970 Impact factor: 2.953